As of Aug 26
| +0.02 / +0.87%|
The 3 analysts offering 12-month price forecasts for Ocera Therapeutics Inc have a median target of 10.00, with a high estimate of 11.00 and a low estimate of 7.00. The median estimate represents a +332.90% increase from the last price of 2.31.
The current consensus among 3 polled investment analysts is to Buy stock in Ocera Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.